Shortridge Emily, Miller Kate
Ibis Reproductive Health, 17 Dunster St., Suite 201, Cambridge, MA 02138, USA.
Contraception. 2007 May;75(5):355-60. doi: 10.1016/j.contraception.2006.12.022. Epub 2007 Mar 26.
The prescription requirement for oral contraceptives (OCs) is designed to prevent women with contraindications from using OCs, but this system has never been evaluated. This analysis investigates OC use among women who have contraindications.
We use National Health and Nutrition Examination Survey data to estimate the prevalence of contraindications among OC users and nonusers. We associate OC use with contraindication status, controlling for sociodemographic characteristics and access to health services.
Overall, 16% of fecund women aged 20 to 51 years are contraindicated from OC use. The prevalence of contraindications among current OC users is 6%, as compared to 19% among nonusers. Regression results show that OC use is more strongly associated with age, race, marital status and health insurance coverage than with having a contraindication to OCs.
The results suggest that under the prescription requirement, screening for contraindications to OCs may be working, but not perfectly. More research is needed to identify more effective and convenient screening methods.
口服避孕药(OCs)的处方要求旨在防止有禁忌证的女性使用OCs,但该系统从未得到评估。本分析调查有禁忌证的女性中OCs的使用情况。
我们使用国家健康与营养检查调查数据来估计OCs使用者和非使用者中禁忌证的患病率。我们将OCs的使用与禁忌证状态相关联,同时控制社会人口学特征和获得医疗服务的情况。
总体而言,20至51岁有生育能力的女性中有16%被列为禁忌使用OCs。当前OCs使用者中禁忌证的患病率为6%,而非使用者中为19%。回归结果表明,OCs的使用与年龄、种族、婚姻状况和医疗保险覆盖范围的关联比与有OCs禁忌证的关联更强。
结果表明,在处方要求下,对OCs禁忌证的筛查可能有效,但并不完美。需要更多研究来确定更有效、更便捷的筛查方法。